Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:6166980

Electron affinity is the major factor influencing radiosensitizing efficiency in vitro. RSU 1069 has an electron affinity similar to misonidazole; however, the ability of this compound to sensitize hypoxic cells is considerably greater in vitro than that of misonidazole. Radiosensitization studies with the MT tumor in vivo also showed RSU 1069 to be a more efficient sensitizer than misonidazole. An administered dose of RSU 1069 yielded an enhancement of 1.8 to 1.9 using tumor cell survival and tumor cure as end-points. At least a 10-fold higher dose of misonidazole is required for a similar degree of sensitization. Low doses of RSU 1069 also radiosensitize the Lewis lung and B16 experimental tumors. The ability of RSU 1069 to potentiate the cytotoxic action of melphalan and other cytotoxic drugs towards the MT tumor was also examined. RSU 1069 given to mice 1 hour before melphalan gave an enhancement of 2.8.

Research Organization:
Medical Research Council, Harwell, England
OSTI ID:
6166980
Report Number(s):
CONF-8311204-
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 10:9; ISSN IOBPD
Country of Publication:
United States
Language:
English